Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Operating Expenses: 2017-2024

Historic Operating Expenses for Puma Biotechnology (PBYI) over the last 8 years, with Dec 2024 value amounting to $199.5 million.

  • Puma Biotechnology's Operating Expenses fell 23.20% to $44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $178.4 million, marking a year-over-year decrease of 15.50%. This contributed to the annual value of $199.5 million for FY2024, which is 1.72% down from last year.
  • According to the latest figures from FY2024, Puma Biotechnology's Operating Expenses is $199.5 million, which was down 1.72% from $203.0 million recorded in FY2023.
  • Puma Biotechnology's 5-year Operating Expenses high stood at $255.5 million for FY2020, and its period low was $199.5 million during FY2024.
  • In the last 3 years, Puma Biotechnology's Operating Expenses had a median value of $203.0 million in 2023 and averaged $202.3 million.
  • Data for Puma Biotechnology's Operating Expenses shows a maximum YoY decreased of 18.88% (in 2022) over the last 5 years.
  • Over the past 5 years, Puma Biotechnology's Operating Expenses (Yearly) stood at $255.5 million in 2020, then fell by 1.43% to $251.9 million in 2021, then dropped by 18.88% to $204.3 million in 2022, then declined by 0.64% to $203.0 million in 2023, then fell by 1.72% to $199.5 million in 2024.